… The results of our analysis with some other suggested drugs indicated that chloroquine and
… approach and virtual screening identified some promising candidate SARS-CoV-2 inhibitors …

… the current COVID-19 … drugs as potential inhibitors of Mpro from SARS-CoV-2; our findings
show that several molecules warrant further analysis as treatment options against COVID-19. …

… modeling screening for potential drugs that may interact with multiple main proteins of … , in
silico screening the FDA approved drugs against multiple proteins of SARS-CoV-2 can provide …

… virtual screening with pre- and postdocking pharmacophore filtering of 6,218 drugs for
COVID-19… Notably, 7 out of 38 compounds showed efficacies in inhibiting SARS-CoV-2 in Vero …

… to identify candidate drugs using a combined approach of virtual drug screening, molecular
… drugs to investigate their potential for repurposing as anti-SARS-CoV-2 drugs as well as two …

… structures of the Main protease, Mpro of SARS-CoV-2 [39], were utilized in the … virtual
screening. Large scale docking studies for rapid identification of potential inhibitors of SARS-CoV-2 …

… , main protease and the SARS-CoV-2 RBD-ACE2 complex (… ) performed a virtual screening
for FDA approved drugs and … a virtual high-throughput screening of known drug databases …

… virtual drug screenings need to use structures with the preserved active site [65, 66]. Interestingly,
we observed that MERS-CoV … These changes may be unfavorable in virtual screening. …

… the SARS-CoV-2 main protease as a potential drug target to screen drugs for repurposing
against COVID-19. … docking-based virtual screening to determine promising inhibitors of novel …

… It is anticipated that the development time of a drug with known side … virtual screen of a
collection of approved drugs against the crystal structure of 3CL pro from SARS-CoV-2 using two …